Oregovomab in combination with non-platinum chemotherapy for the treatment of PARP inhibitor– and platinum-resistant ovarian cancer: A two-cohort, single-arm phase 2 study (OPERA/KGOG3065/APGOT-OV6).

Authors: Junsik Park, Hyun Woong Cho, Myong Cheol Lim, Chel Hun Choi, Jung-Yun Lee

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.5587

Source: Full article

5587